The higher GLUT4 expression on NK cells in patients with type 2 diabetes but without cancer is probably associated with compensative mechanism, which is responsible for proper glucose transport to these cells despite insulin resistance and hyperglycemia. The gene discussed is SLC2A4; the disease is cancer.